Amvuttra (vutrisiran)
pCPA File Number:
22562
Negotiation Status:
Active Negotiation
Indication(s):
Hereditary transthyretin-mediated amyloidosis
Sponsor/Manufacturer:
Alnylam Netherlands B.V.
CDA-AMC Project Number:
SR0801-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable